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RESULTS FROM  
SYSTEMATIC  
LITERATURE REVIEW  
ON PE/E IN BANGLADESH
BACKGROUND AND INTRODUCTION 
The Ending Eclampsia project seeks to expand 
access to proven,underutilized interventions and 
commodities for the prevention, early detection, 
and treatment of pre-eclampsia and eclampsia and 
strengthen global partnerships. 
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• Pre-eclampsia is a condition               
in pregnant women marked by an 
increase in blood pressure and 
protein in urine after 20 weeks 
gestation.
• Providing high quality antenatal 
care improves the prevention and 
early detection of pre-eclampsia 
and can prevent its progression to 
eclampsia.
• Eclampsia is a life-threatening 
condition characterized by 
convulsions in women with PE.
• Women in developing countries 
are 300 times more likely to die 
from eclampsia than women in 
developed countries.
• Prescribing low-dose aspirin 
and calcium to at-risk women 
can prevent pre-eclampsia and 
eclampsia.
• Pre-eclampsia and eclampsia can 
be managed by administering 
anti-hypertensive drugs and 
magnesium sulphate (MgSO4).
• MgSO4 is the safest and most 
effective treatment for severe 
PE/E, and is one of 13 UN Life-
Saving Commodities for Women 
and Children. 
• PE/E and other hypertensive 
disorders in pregnancy increase 
the risk of pre-term births, which 
can lead to low birth weight, 
anemia, and stunting.
• Improved prevention, increased 
detection, and effective treatment 
of PE/E can prevent unnecessary 
maternal and newborn deaths.
PE/E in Brief
Hypertensive disorders of pregnancy are major causes of severe morbidity, 
long-term disability, and deaths of mothers and their babies. About 10 
percent of women experience increased blood pressure during pregnancy 
and 8 percent of pregnancies develop pre-eclampsia. Among pre-eclampsia 
patients, about 10 percent develop eclampsia. Globally, about 10 to 20 
percent maternal deaths are associated with eclampsia. 
By 2015, at the conclusion of the Millenium Development Goals, Bangladesh 
had achieved a reduction in maternal death from 550 per 100,000 live births 
in 1990, to 170 maternal deaths per 100,000 live births in 2015. Despite 
this progress, there are still between 5,000 and 6,000 maternal deaths every 
year in Bangladesh, where 20 percent are the result of pre-eclampsia and 
eclampsia (PE/E). 
This systematic review of peer-reviewed literature published between January 
2000 and July 2016 identified interventions adopted to manage PE/E 
throughout Bangladesh. Specifically, it looked at issues around quality of care, 
gaps in the evidence, and barriers to accessing PE/E services.
APPROACH
The research team developed two sets of key search terms linking various 
aspects of the diagnosis, treatment, and prevention of PE/E and other 
hypertensive disorders of pregnancy. The team limited searches to peer-
reviewed articles published between January 2000 and July 2016, and 
ran the articles in PubMed and ScienceDirect. Two independent reviewers 
excluded any duplicate or non-English citations or citations without relevant 
titles prior to Phase I. The reviewers then imported the titles and abstracts for 
the articles into an Excel spreadsheet for independent review. They then read 
and evaluated the results in three phases: Abstract and title review, full text 
review, and categorization of papers (Figure 1).
FIGURE 1: Flow chart of review process
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THEMES 
From the literature, the reviewers identified several 
themes, ranging from treatment and prevention 
strategies, risk factors, and health outcomes for women 
and babies. 
Strategies for prevention and treatment
The papers that examined hypotheses for improving PE/E 
prevention, detection, and management of examined 
strategies for prevention, approaches to improve detection 
and new mechanisms for PE/E management, and delivery 
mode. Prevention strategies looked at dietary calcium 
supplementation, plus conjugated linoleic acid (CLA), and 
methods of calcium supplementation, and concluded 
that calcium+CLA impacted the reduction of “vascular 
endothelial dysfunction”vascular endothelial dysfunction 
in pregnant women at high risk of hypertensive disorders 
of pregnancy. 
To improve detection of pre-eclampsia, one intervention 
used village theater to increase community knowledge 
on eclampsia and another improved detection of pre-
eclampsia by testing the accuracy of a 12-hour urine 
sample compared to 24-hour sample. Also according to 
the literature, community health workers (CHWs) can 
provide maternity care with referral services for obstetric 
emergencies, which increase care seeking behaviors for 
life-threatening conditions during pregnancy.
New mechanisms for PE/E management included a 
new protocol for administering antihypertensive drugs 
to pregnant women. Reduced time between onset 
of symptoms and administration of the loading dose 
of MgSO4 at a patient’s home, rather than waiting 
until she arrives in a facility; and another reduced the 
overall dosage of MgSO4 and prolonging pregnancy by 
conservatively managing PE/E cases. None of the studies 
identified in this review used the global standard of care, 
the Pritchard Regimen, but instead used a lower 10g 
dose and one used 8g IV dose. These studies indicate 
that there is likely a lower effective dose than the globally-
accepted 14g dose. 
For women with PE/E, delivering via cesarean section 
appeared safer than vaginal delivery, and spinal 
anesthesia is as safe as general anesthesia for cesarean 
deliveries.
Demonstrated and potential risk factors 
Many studies identified risk factors associated with PE/E. 
In the 38 reviewed journal articles, two primary themes 
emerged: Micronutrient deficiencies among pregnant 
women and a woman’s past medical history with 
autoimmune disorders like diabetes, and hypertension, 
or obesity. Other articles discussed elevated enzyme or 
hormone levels, birth spacing, health-seeking behaviors, 
maternal age, and poor-quality antenatal care. Levels 
of serum homocysteine, serum beta-human chorionic 
gonadotropin, plasma neuropeptide Y concentration 
levels, serum total bilirubin and alanine aminotransferase, 
and serum C reactive protein were found to be higher in 
women with PE/E and selenium levels and platelet counts 
were lower, compared to normal pregnancies.
The role of micronutrient deficiencies in the development 
of PE/E was a major focus in the literature. Specifically, 
researchers examined the connection between PE/E and 
calcium in pregnant women and found that calcium intake 
was lower among women with PE/E than normotensive 
pregnant women. Vitamin D insufficiency showed a 
3-5 fold increase in risk for developing PE/E. From the 
literature, zinc and magnesium deficiencies also play a 
role in the pathogenesis of PE/E. Another micronutrient 
examined was serum magnesium, which was low in mild 
pre-eclampsia, and even lower in severe PE. One study 
found that pre-eclamptic women had lower levels of zinc, 
copper, manganese, ferritin, and iron, while others found 
high levels of iron and ferritin in mild and severe PE cases. 
Researchers also looked at pregnant women’s history of 
diabetes, high BMI, cholesterol concentration, abnormal 
thyroid function, and hypertension to further understand 
what puts a woman at risk of developing the disorder.  and 
potentially, as may be the case for diabetes, if it increases 
preterm birth, and low birth weight.
1. Vascular endothelial dysfunction is a key event in cardiovascular and renal dis-
ease. It affects the lining of the blood vessels.
LOOKING FORWARD
Despite the wealth of information in the literature on PE/E 
in Bangladesh, there are still gaps that require further 
research. These gaps include the need for clearer clinical 
guidelines and definitions, dosage variations, community 
awareness and the most appropriate, effective 
mechanisms for reducing micronutrient deficiencies.
Definitions
Generally speaking, “toxemia” is an outdated term not 
frequently used to now classify hypertensive disorders 
of pregnancy. However, several articles use the term, 
with only two providing definitions. Definitions for “pre-
eclampsia” appeared in many articles, but each set its 
own standard clinical requirement for diagnosis. The 
majority include high blood pressure, but with variations 
of clinical definitions. In low service utilization settings, 
providers may not encounter cases of PE/E regularly and 
Other maternal health outcomes 
Heath consequences that follow, or are associated with, 
PE/E can negatively affect maternal, fetal, newborn, 
or child health outcomes. Maternal health outcomes 
associated with PE/E often include increased rates 
of cesarean section, reduced organ function, HELLP 
syndrome, and ocular changes. Additional results from 
the literature show that reduced placental size and 
weight, pulmonary edema, postpartum hemorrhage, 
cardiovascular accident, and obstetric shock also 
appeared as other health outcomes associated with 
PE/E. 
For newborns and children of women with PE/E,  health 
outcomes that emerged from the literature were stillbirth, 
perinatal and neonatal mortality, low birth weight, preterm 
birth, intrauterine growth retardation (IUGR), respiratory 
distress, and potentially include cerebral palsy. 
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may not easily recall the nuanced distinctions between 
the terms along the spectrum of hypertensive disorders of 
pregnancy. In order to enable these providers to diagnose 
and manage PE/E promptly, accurately, and thoroughly, 
clearer diagnosis guidelines must align with streamlined 
and precise definitions and management protocols. 
Lowest effective dose of MgSO4
Globally, there are two predominant regimens for 
administering MgSO4 to women with severe PE/E: 
Pritchard and Zuspan. The Pritchard regimen is 
considered the ‘gold standard’ treatment method in low 
resource settings, while the Zuspan regimen requires 
more medical skills and equipment. While there is 
evidence to support the effectiveness of both regimens, 
there is no evidence on whether either regimen provides 
the lowest effective dosage for controlling convulsions. 
The literature forces us to think about the evidence behind 
the ‘standard’ regimens requiring massive amounts of 
MgSO4. Anecdotally, the small size of Bangladeshi women 
is cited as the reason why lower doses are adequate, but 
this requires more research. What characteristics would 
require a woman to be given a larger dose? 
Community awareness and knowledge 
Based on the literature, community awareness of danger 
signs and symptoms is low. Increasing awareness of 
issues related to pregnancy, specifically PE/E, can lead 
to improved health-seeking behavior and therefore better 
health outcomes. As women in these settings are often 
not the decision makers in a household, it is critical that 
these health messages target other members of the 
community, such as husbands and mothers-in-law with 
the hope that they will recognize dangerous symptoms 
and encourage pregnant women to access health 
services, attend early antenatal care visits that include 
blood pressure measurements.
Micronutrient deficiencies, clinical biomarkers, and 
trace elements 
The most common risk factors discussed in the literature 
were micronutrient deficiencies, primarily calcium and 
magnesium, but also iron, zinc, ferritin, and copper. 
The literature shows that micronutrient deficiencies 
are a serious matter that needs attention, but it does 
not discuss the cutoff levels for deficiencies or the 
most effective, appropriate mechanisms for reducing 
deficiencies, i.e. dietary supplements and in which form? 
Limitations
The published research revealed some gaps for PE/E 
prevention, detection, and treatment in Bangladesh. The 
first is the limited understanding of providers’ perceptions 
and working environment.  There is a lack of input from 
the providers at any tier of the health system who are 
working to reduce maternal and neonatal deaths from 
PE/E. Most of the research focused on the experiences 
of PE/E patients and their families, but it did not look 
at the ways in which facility providers are hindered or 
prevented in their work to manage hypertensive disorders 
of pregnancy. Their voice is a powerful one that needs to 
be heard.  
Another limitation was that 76 out of 94 articles focuses on 
urban settings, with few speaking to the experience of rural 
women, their families, or providers at primary health care 
facilities. As urban women are most likely closer to health 
services, the reviewers felt due to the lack of research 
focused on rural women, that their unique needs and 
opportunities for accessing quality services are unclear.
Recommendations
• Determine variables that impact efficacy of lower doses 
and generate a clear, evidence-based dosing regimen 
that uses the lowest, effective dose of MgSO4;
• Simplify terminology used to discuss hypertensive 
disorders of pregnancy, and establish clear clinical 
guidelines to define each term for improved diagnosis;
• Work within communities to improve early antenatal 
care and increase awareness of danger signs in 
pregnancy; 
• Support task shifting initiatives that allow primary 
health center providers to administer the MgSO4 
loading dose; 
• Monitor women for up to one year postpartum to 
understand the impact of PE/E and extent of follow up 
women receive;
• Research the most effective, lowest-cost, and 
least invasive means of administering nutritional 
supplements that reduce micronutrient deficiencies, 
and define protocols for analysis during antenatal care 
check-ups; and
• Learn more about the unique needs of rural woman 
and their families. 
